Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) has provided an announcement.
MedPlus Health Services Ltd. announced that its subsidiary, Optival Health Solutions Private Limited, has received suspension orders for drug licenses at two of its store locations in Karnataka and Telangana. The suspensions, lasting five and three days respectively, are due to violations under the Drugs and Cosmetics Act and Rules. The company anticipates a potential revenue loss of approximately Rs 1.97 lacs, impacting its financial operations slightly. This development may affect the company’s operational efficiency and stakeholder confidence in the short term.
More about MedPlus Health Services Ltd.
MedPlus Health Services Ltd. operates in the healthcare industry, primarily focusing on providing pharmaceutical and health-related services. The company is known for its extensive network of retail pharmacy outlets across India, catering to a wide range of consumer health needs.
Average Trading Volume: 20,925
Technical Sentiment Signal: Hold
Current Market Cap: 94.31B INR
See more data about MEDPLUS stock on TipRanks’ Stock Analysis page.